000			01341 a2200361 4500
005			20250510215321.0
264		0	_c19780223
008			197802s 0 0 eng d
022			_a0036-8075
024	7		_a10.1126/science.202024 _2doi
040			_aNLM _beng _cNLM
100	1		_aU'Prichard, D C
245	0	0	_aTricyclic antidepressants: therapeutic properties and affinity for alpha-noradrenergic receptor binding sites in the brain. _h[electronic resource]
260			_bScience (New York, N.Y.) _cJan 1978
300			_a197-8 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
650	0	4	_aAnimals
650	0	4	_aAntidepressive Agents, Tricyclic _xmetabolism
650	0	4	_aBinding, Competitive
650	0	4	_aBrain _xmetabolism
650	0	4	_aHumans
650	0	4	_aHypotension _xchemically induced
650	0	4	_aPsychomotor Agitation _xdrug therapy
650	0	4	_aRats
650	0	4	_aReceptors, Adrenergic _xmetabolism
650	0	4	_aReceptors, Adrenergic, alpha _xmetabolism
650	0	4	_aStructure-Activity Relationship
700	1		_aGreenberg, D A
700	1		_aSheehan, P P
700	1		_aSnyder, S H
773	0		_tScience (New York, N.Y.) _gvol. 199 _gno. 4325 _gp. 197-8
856	4	0	_uhttps://doi.org/10.1126/science.202024 _zAvailable from publisher's website
999			_c197837 _d197837